|
TMPPE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.399000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.759600E-04 |
| Normal-vs-Stage2 |
1.493170E-01 |
| Normal-vs-Stage3 |
1.953600E-01 |
| Normal-vs-Stage4 |
2.026600E-04 |
| Stage1-vs-Stage2 |
4.621800E-01 |
| Stage1-vs-Stage3 |
7.183600E-01 |
| Stage1-vs-Stage4 |
1.290390E-01 |
| Stage2-vs-Stage3 |
8.778400E-01 |
| Stage2-vs-Stage4 |
8.210200E-02 |
| Stage3-vs-Stage4 |
1.486550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.842500E-03 |
| Normal-vs-AfricanAmerican |
1.624940E-03 |
| Normal-vs-Asian |
2.778400E-04 |
| Caucasian-vs-AfricanAmerican |
4.404800E-01 |
| Caucasian-vs-Asian |
2.423900E-03 |
| AfricanAmerican-vs-Asian |
1.104380E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.26770000000865E-05 |
| Normal-vs-Female |
9.124400E-01 |
| Male-vs-Female |
3.060700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.838500E-03 |
| Normal-vs-Extreme_Weight |
8.21870000000668E-05 |
| Normal-vs-Obese |
1.829400E-01 |
| Normal-vs-Extreme_Obese |
3.131600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.133000E-01 |
| Normal_Weight-vs-Obese |
1.643350E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.577600E-01 |
| Extreme_Weight-vs-Obese |
4.058400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.899000E-01 |
| Obese-vs-Extreme_Obese |
5.182600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.735000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.572100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.368000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.53290000000684E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.027600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.199000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.934000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.139180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.102400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.646300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.201240E-03 |
| Normal-VS-Type2 PRCC |
1.406490E-04 |
| Normal-VS-KIRP CIMP |
6.339200E-01 |
| Normal-VS-Unclassified PRCC |
9.059200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.579250E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.178200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.042040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.305980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.611700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.707200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.962350E-04 |
| Normal-vs-N1 |
1.008750E-01 |
| Normal-vs-N2 |
3.756600E-01 |
| N0-vs-N1 |
5.817000E-01 |
| N0-vs-N2 |
9.364000E-01 |
| N1-vs-N2 |
8.577200E-01 |
|
|
